Ignyte Acquisition Corp. (IGNY) to Combine with Peak Bio in $205M Deal

Ignyte (NASDAQ:IGNY) has entered into a definitive agreement to combine with biotech firm Peak Bio at an enterprise value of $205 million. Silicon Valley-based Peak Bio is currently developing treatments for respiratory illnesses and cancer. The combined company is expected to trade on the Nasdaq under the symbol “PKBO” once the deal is completed in
Read More